Literature DB >> 2108406

Effect of Klebsiella ozaenae on ciliary activity in vitro: implications in the pathogenesis of atrophic rhinitis.

J L Ferguson1, T V McCaffrey, E B Kern, W J Martin.   

Abstract

Klebsiella ozaenae is a gram-negative rod that has been isolated with relative frequency from patients with atrophic rhinitis. The relationship of this bacterium to the pathogenesis of atrophic rhinitis is not understood, and whether this bacterium is simply an opportunistic colonizer of the injured nose or the etiologic agent of the disease is unclear. This study was designed to investigate a potential role for bacterially produced cilioinhibition as a mechanism for the pathogenesis of atrophic rhinitis.

Entities:  

Mesh:

Year:  1990        PMID: 2108406     DOI: 10.1177/019459989010200301

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  5 in total

1.  Clinical, genetic and immunologic analysis of a family affected by ozena.

Authors:  Lucia Medina; Marco Benazzo; Giulia Bertino; Carlo Maurizio Montecucco; Cesare Danesino; Miryam Martinetti; Eugenio Mira
Journal:  Eur Arch Otorhinolaryngol       Date:  2003-03-26       Impact factor: 2.503

2.  Ozena in Immigrants of Differing Backgrounds.

Authors:  Mallory J Yelenich-Huss; Holly Boyer; Jonathan D Alpern; William M Stauffer; Derek Schmidt
Journal:  Am J Trop Med Hyg       Date:  2016-04-25       Impact factor: 2.345

3.  Primary atrophic rhinitis: a clinical profile, microbiological and radiological study.

Authors:  Sampan S Bist; Manisha Bisht; Jagdish P Purohit
Journal:  ISRN Otolaryngol       Date:  2012-11-19

4.  Skull base defect in a patient with ozena undergoing dacryocystorhinostomy.

Authors:  Mark E Friedel; Marisa A Earley; Jean Anderson Eloy
Journal:  Allergy Rhinol (Providence)       Date:  2011-01

5.  BSACI guidelines for the management of allergic and non-allergic rhinitis.

Authors:  G K Scadding; S R Durham; R Mirakian; N S Jones; S C Leech; S Farooque; D Ryan; S M Walker; A T Clark; T A Dixon; S R A Jolles; N Siddique; P Cullinan; P H Howarth; S M Nasser
Journal:  Clin Exp Allergy       Date:  2008-01       Impact factor: 5.018

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.